Date published: 2026-5-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

CBWD3 Inhibitors

CBWD3 inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity of the CBWD3 enzyme, which is part of the CBWD (Cobalamin binding domain-containing) protein family. CBWD3 enzymes are thought to play a role in processes related to the regulation of cobalamin (vitamin B12) metabolism and may also be involved in protein interactions and intracellular signaling pathways. Inhibitors of CBWD3 function by binding to critical regions of the enzyme, such as the cobalamin-binding domain or other active sites essential for its biochemical activity. By occupying these sites, CBWD3 inhibitors block the enzyme's ability to bind with its substrates or cofactors, thereby preventing it from catalyzing reactions that require the involvement of cobalamin or other biomolecules. These inhibitors serve as essential tools for understanding the precise biological role of CBWD3 in cellular metabolism and related biochemical pathways.

Structurally, CBWD3 inhibitors are designed to interact with key amino acid residues within the enzyme's binding pocket, often forming specific molecular interactions such as hydrogen bonds, ionic interactions, or hydrophobic contacts. Some inhibitors may mimic the enzyme's natural substrates, competing for binding at the active site, while others may function through allosteric inhibition, binding to non-active sites and inducing conformational changes that impair enzyme function. The design and optimization of CBWD3 inhibitors typically utilize structural biology techniques such as X-ray crystallography, molecular docking studies, and computational modeling to identify binding sites and refine inhibitor specificity. By targeting CBWD3 with selective inhibitors, researchers can probe its functional role in biological processes, including its contribution to maintaining cellular homeostasis, protein processing, and potentially its involvement in cobalamin-dependent metabolic reactions. These inhibitors are instrumental in deepening our understanding of CBWD3 and its broader biochemical significance.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

A potent kinase inhibitor that can inhibit a wide range of protein kinases, possibly affecting kinase-dependent regulation of CBWD3.

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$39.00
$59.00
$104.00
$206.00
8
(1)

Binds to HSP90 and inhibits its chaperone activity, which can destabilize client proteins and may affect CBWD3 folding or stability.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Inhibits eukaryotic protein synthesis by interfering with the translocation step, potentially reducing the synthesis of CBWD3.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Interacts with DNA and inhibits RNA synthesis, which can decrease the transcription of genes, including potentially the gene of CBWD3.

Mitomycin C

50-07-7sc-3514A
sc-3514
sc-3514B
2 mg
5 mg
10 mg
$66.00
$101.00
$143.00
85
(5)

Crosslinks DNA, which can inhibit DNA replication and transcription, possibly affecting CBWD3 expression.

2-Deoxy-D-glucose

154-17-6sc-202010
sc-202010A
1 g
5 g
$70.00
$215.00
26
(2)

Glycolysis inhibitor that can alter energy metabolism, potentially impacting the cellular context of CBWD3 function.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Disrupts the structure and function of the Golgi apparatus, which can affect protein trafficking and potentially CBWD3 localization.

Alsterpaullone

237430-03-4sc-202453
sc-202453A
1 mg
5 mg
$68.00
$312.00
2
(1)

Cyclin-dependent kinase inhibitor that can interfere with cell cycle progression and possibly influence CBWD3 activity.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

Selective MEK inhibitor that can prevent ERK activation, potentially affecting CBWD3 if it is regulated by this pathway.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

Proteasome inhibitor that can prevent the degradation of proteins, potentially stabilizing CBWD3 if it is prone to proteasomal degradation.